Search for: "AMGEN INC."
Results 381 - 400
of 704
Sort by Relevance
|
Sort by Date
18 Aug 2013, 8:54 pm
Amgen Inc. et al. v. [read post]
6 Aug 2013, 8:36 am
See Southwall Tech., Inc. v. [read post]
31 Jul 2013, 5:25 pm
Medline Industries, Inc.). [read post]
31 Jul 2013, 4:25 pm
Medline Industries, Inc.). [read post]
18 Jul 2013, 12:00 pm
The SECobtained an emergency court order to freeze the assets of traders using foreign accounts to reap approximately $4.6 million in potentially illegal profits by trading in advance of the Sunday, June 30, 2013 announcement that Onyx Pharmaceuticals, Inc. had received, but rejected an acquisition offer from Amgen, Inc.The SEC alleges that unknown traders took risky bets that Onyx's stock price would increase by purchasing call options on June 26, 27 and 28, the three trading days… [read post]
30 Jun 2013, 10:03 pm
Amgen Inc. v. [read post]
27 Jun 2013, 12:30 pm
The OIG featured the following items in its semiannual report: • 1,661 individuals and entities were excluded from participation in Federal healthcare programs• 484 criminal actions and 240 civil actions against individuals and entities responsible for crimes against HHS programs and civil actions such as false claims and unjust enrichment lawsuits filed in Federal district court, civil monetary penalties (CMP) settlements, administrative recoveries related to provider self-disclosure… [read post]
21 Jun 2013, 11:26 am
The Fifth Circuit adopted the same analysis the United States Supreme Court used in Amgen Inc. v. [read post]
13 Jun 2013, 11:51 am
In Oxford Health Plans, LLC v. [read post]
4 Jun 2013, 8:45 am
Wal-Mart including an analysis of the Supreme Court’s decisions in Amgen Inc. v. [read post]
14 May 2013, 2:11 pm
On February 27, 2013 the Supreme Court announced its decision in Amgen Inc. v. [read post]
14 May 2013, 2:11 pm
On February 27, 2013 the Supreme Court announced its decision in Amgen Inc. v. [read post]
10 May 2013, 6:00 am
Noah Levine, who represented the defendant in Amgen Inc. v. [read post]
24 Apr 2013, 7:06 am
The abstract provides: Commentary and analysis of the Supreme Court’s February and March 2013, decisions in three major class action appeals: Amgen Inc. v.... [read post]
22 Apr 2013, 5:19 pm
California-based biotechnology giant Amgen, Inc. has agreed to pay $24,9 Million to resolve Justice Department False Claims Act charges that the biotechnology giant violated the False Claims Act by paying illegal kickbacks to long-term care pharmacy providers to promote the sale of its Aranesp and other products. [read post]
16 Apr 2013, 5:34 am
Omnicare, Inc. [read post]
14 Apr 2013, 11:19 pm
Food and Drug Administration ("FDA") approved the Omontys (peginesatide) injection, pharmaceutical company Affymax, Inc. [read post]
14 Apr 2013, 8:41 pm
Joshua Sarnoff of the DePaul University College of Law; and Stuart Watt of Amgen Inc. will discuss the Justices' questioning during oral argument in AMP v. [read post]
9 Apr 2013, 9:01 pm
Behrend—does not even cite the first case—Amgen Inc. v. [read post]
29 Mar 2013, 9:27 am
Plaintiffs’ lawyers took heart as to gaining such routine certification of class actions when the Supreme Court handed down its decision in Amgen, Inc. v. [read post]
